Quintiles和肌肉萎缩症学会签定研究协议

2013-10-21 yangtao 生物谷

Quintiles公司在本月14号公布公司和肌肉萎缩症学会达成合作协议,帮助其处理患者数据以开发新疗法。根据协议,在未来三年,Quintiles将在全美招募登记患者信息并建立数据库供研究人员研究肌肉萎缩症发病历史和相关疾病情况。信息收集工作将从肌肉萎缩性侧索硬化症和贝克型肌营养不良症等几种疾病开始直到2016年。这一协议无疑将增强Quintiles公司在该领域的实力。公司预计2013年的营业增

Quintiles公司在本月14号公布公司和肌肉萎缩症学会达成合作协议,帮助其处理患者数据以开发新疗法。根据协议,在未来三年,Quintiles将在全美招募登记患者信息并建立数据库供研究人员研究肌肉萎缩症发病历史和相关疾病情况。信息收集工作将从肌肉萎缩性侧索硬化症和贝克型肌营养不良症等几种疾病开始直到2016年。这一协议无疑将增强Quintiles公司在该领域的实力。公司预计2013年的营业增长在3.8% 到5.2%之间。


原文检索:

Damian Garde.Quintiles snags registry deal with Muscular Dystrophy Association.October 14, 2013 .Fierce CRO.

(

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1695735, encodeId=4fb71695e35c4, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Sat Apr 19 02:46:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584170, encodeId=d31515841e096, content=<a href='/topic/show?id=f3308101eee' target=_blank style='color:#2F92EE;'>#肌肉萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81017, encryptionId=f3308101eee, topicName=肌肉萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=177b17012429, createdName=12498ebem24暂无昵称, createdTime=Wed Oct 23 00:46:00 CST 2013, time=2013-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614078, encodeId=262916140e8db, content=<a href='/topic/show?id=b05281019f8' target=_blank style='color:#2F92EE;'>#肌肉萎缩症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81019, encryptionId=b05281019f8, topicName=肌肉萎缩症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28719479710, createdName=12498768m19(暂无昵称), createdTime=Wed Oct 23 00:46:00 CST 2013, time=2013-10-23, status=1, ipAttribution=)]
    2014-04-19 chendoc252
  2. [GetPortalCommentsPageByObjectIdResponse(id=1695735, encodeId=4fb71695e35c4, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Sat Apr 19 02:46:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584170, encodeId=d31515841e096, content=<a href='/topic/show?id=f3308101eee' target=_blank style='color:#2F92EE;'>#肌肉萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81017, encryptionId=f3308101eee, topicName=肌肉萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=177b17012429, createdName=12498ebem24暂无昵称, createdTime=Wed Oct 23 00:46:00 CST 2013, time=2013-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614078, encodeId=262916140e8db, content=<a href='/topic/show?id=b05281019f8' target=_blank style='color:#2F92EE;'>#肌肉萎缩症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81019, encryptionId=b05281019f8, topicName=肌肉萎缩症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28719479710, createdName=12498768m19(暂无昵称), createdTime=Wed Oct 23 00:46:00 CST 2013, time=2013-10-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1695735, encodeId=4fb71695e35c4, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Sat Apr 19 02:46:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584170, encodeId=d31515841e096, content=<a href='/topic/show?id=f3308101eee' target=_blank style='color:#2F92EE;'>#肌肉萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81017, encryptionId=f3308101eee, topicName=肌肉萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=177b17012429, createdName=12498ebem24暂无昵称, createdTime=Wed Oct 23 00:46:00 CST 2013, time=2013-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614078, encodeId=262916140e8db, content=<a href='/topic/show?id=b05281019f8' target=_blank style='color:#2F92EE;'>#肌肉萎缩症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81019, encryptionId=b05281019f8, topicName=肌肉萎缩症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28719479710, createdName=12498768m19(暂无昵称), createdTime=Wed Oct 23 00:46:00 CST 2013, time=2013-10-23, status=1, ipAttribution=)]

相关资讯

CRO巨头昆泰(Quintiles)收购Novella Clinical公司

2013年8月14日 Quintiles Transnational宣布签订协议,将收购Novella Clinical (Novella),後者为专注新兴肿瘤客户、医疗器材、诊断业者的完整服务临床研究组织。 Quintiles to Acquire Novella Clinical Acquisition bolster